# seragy holding GmbH Secures 12 Million Euros to Expand Biomarker Platform

- URL: https://stocks.freetheai.org/news/seragy-holding-gmbh-secures-12-million-euros-to-expand-biomarker-platform-517534
- Published: 2026-10-14T08:00:04Z
- Category: company_news; sentiment: bullish; impact: low
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Biotechnology startup seragy holding GmbH raised 12 million euros in fresh financing from Commerzbank, MBG, and the State of Lower Saxony. The company, founded in 2022, will use the capital to build out its proprietary SeRAS biomarker platform, expand its laboratory footprint, enhance its analytics capabilities, and hire additional team members.

The capital injection provides needed runway for the company to scale its research, development, and operational capacity. Backing from established institutions like Commerzbank and public state investors helps validate the technology while lowering execution risks. The business also secured non-dilutive support via a grant from the Michael J. Fox Foundation to develop a Parkinson's disease assay.

Looking ahead, key catalysts for the early-stage business include commercial progress through paid pharmaceutical partnerships, further validation data for its biomarker assays, and regulatory milestones that could translate platform development into sustainable revenue.

## Key points

- seragy holding GmbH raised 12 million euros from Commerzbank, MBG, and the State of Lower Saxony.
- The funds will expand the SeRAS biomarker platform, scale up laboratories, and grow the team.
- The company secured grant funding from the Michael J. Fox Foundation for a Parkinson's assay.
- The capital extends operational runway for research and commercial development.

## Questions and answers

### How much financing did seragy holding GmbH raise?

seragy holding GmbH raised 12 million euros from Commerzbank, MBG, and the State of Lower Saxony to expand its laboratory operations and advance its biomarker platform.

### What is seragy holding GmbH using the new funding for?

The company plans to use the 12 million euros to develop its SeRAS biomarker platform, expand its lab and analytics facilities, and hire additional personnel.

### Who invested in seragy holding GmbH's latest funding round?

The funding round was backed by Commerzbank, MBG, and the State of Lower Saxony, along with grant support from the Michael J. Fox Foundation for a Parkinson's assay.